Surescripts names Frank Harvey as new CEO

Print Friendly, PDF & Email

ARLINGTON, Va.  – Surescripts has appointed Frank Harvey as chief executive officer, effective June 27. Harvey succeeds Tom Skelton, who previously announced his decision to retire.

Frank Harvey

Harvey is a pharmacist and an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. Harvey joins Surescripts from ATLS Investments, LLC. where he led private equity investing in healthcare technology companies. Previously, Harvey served as Chief Executive Officer of Mirixa Corporation and Liberty Medical Supply, Inc.

“It’s been a pleasure to work closely with Tom over the past eight years, and we appreciate the many successes that Surescripts achieved under his leadership,” explained Dr. Steven Miller, co-chair of Surescripts’ Board of Directors. “We are now poised for continued growth and new opportunities with Frank’s leadership at this incredible time in healthcare.”

“Frank is a results-oriented leader with strong operational skills, and extensive experience growing healthcare businesses,” said Douglas Hoey, co-chair of Surescripts’ board of directors. “Frank combines his unique perspective and depth of experience with a passion for improving the lives of patients and evolving the healthcare system.”

“I’m honored to join Surescripts at such a critical time, and I look forward to working with the team to realize the enormous potential we have to change healthcare,” Harvey shared. “I’m committed to what we do as a company and the new products and services we will bring to market that I believe will have a significant impact on the healthcare system as a whole.”


Comments are closed.